Detalhe da pesquisa
1.
Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein.
Immunity;
55(9): 1710-1724.e8, 2022 09 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35944529
2.
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.
Proc Natl Acad Sci U S A;
109(22): 8546-51, 2012 May 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22586108
3.
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.
Neurobiol Dis;
56: 6-13, 2013 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23583610
4.
Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
PLoS Pathog;
7(7): e1002128, 2011 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21779169
5.
Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease.
Mol Ther;
20(7): 1393-9, 2012 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22588273
6.
Evolution of antibody immunity following Omicron BA.1 breakthrough infection.
Nat Commun;
14(1): 2751, 2023 05 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37173311
7.
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers.
Sci Transl Med;
15(688): eadg2783, 2023 03 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36947596
8.
Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody.
Sci Transl Med;
15(700): eadg1855, 2023 06 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37315110
9.
Evolution of antibody immunity following Omicron BA.1 breakthrough infection.
bioRxiv;
2022 Sep 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36172124
10.
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
Sci Transl Med;
14(636): eabl5399, 2022 03 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35294259
11.
Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor.
PLoS Pathog;
5(7): e1000535, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19649330
12.
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
Sci Immunol;
6(56)2021 02 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33622975
13.
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
Science;
371(6531): 823-829, 2021 02 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33495307
14.
Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro.
Biochemistry;
49(18): 3928-34, 2010 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20377181
15.
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19.
bioRxiv;
2020 Nov 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33236009
16.
Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Sträussler-Scheinker syndrome.
J Neurosci;
26(48): 12408-14, 2006 Nov 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17135402
17.
On the horizon: a blood test for prions.
Trends Microbiol;
14(4): 149-51, 2006 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16483780
18.
Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth.
Cancer Res;
65(23): 11101-8, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16322260
19.
Chaperone proteins as single component reagents to assess antibody nonspecificity.
MAbs;
9(7): 1036-1040, 2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28745541
20.
Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.
MAbs;
8(5): 941-50, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27050875